LG. Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice. Am J Physiol Renal Physiol 293: F938-F945, 2007. First published July 18, 2007; doi:10.1152/ajprenal.00146.2007.-This study was performed in transgenic mice to test the hypothesis that the selective intrarenal overproduction of ANG II increases intrarenal mouse (m) angiotensinogen (AGT) expression. We used the following three groups: 1) single transgenic mice (group A, n ϭ 14) expressing human (h) AGT only in the kidney, 2) double-transgenic mice (group D, n ϭ 13) expressing human renin systemically in addition to hAGT only in the kidney, and 3) wild-type (group W, n ϭ 12) mice. Exogenous hAGT protein is inactive in group A because endogenous mouse renin cannot cleave hAGT to ANG I because of a high species specificity. All mice were monitored from 12 to 18 wk of age. Systolic blood pressure progressively increased from 116 Ϯ 5 mmHg (12 wk) to 140 Ϯ 7 (18 wk) in group D. This increase was not observed in groups A or W. Intrarenal hAGT levels were similar in groups A and D; however, hAGT was not detectable in kidneys of group W. Kidney ANG II levels were increased in group D (216 Ϯ 43 fmol/g) compared with groups A (117 Ϯ 16) and W (118 Ϯ 17). However, plasma ANG II concentrations were similar among the three groups. Endogenous renal mAGT mRNA was increased significantly in group D (1.46 Ϯ 0.19, ratio) compared with groups A (0.97 Ϯ 0.12) and W (1.00 Ϯ 0.08). Endogenous renal mAGT protein was also significantly increased in group D compared with groups A and W. Interstitial collagen-positive area, interstitial macrophage/monocyte infiltration, and afferent arteriolar wall thickness were increased significantly in group D compared with groups A and W. These data indicate for the first time that the selective stimulation of intrarenal production of ANG II from hAGT augments endogenous intrarenal mAGT mRNA and protein expression.hypertension; transgenic mouse; angiotensin II; renal injury RECENT ATTENTION HAS BEEN focused on the existence of unique renin-angiotensin systems (RAS) in various tissues (10). Emerging evidence has demonstrated the importance of the tissue RAS in the brain (1), heart (7), adrenal glands (34), vasculature (5,13,15,36), and kidneys (37). The RAS has been acknowledged as an endocrine, paracrine, autocrine, and intracrine system and thus it has been difficult to delineate the quantitative contributions of systemically delivered vs. locally formed ANG peptides to the levels existing in any given tissue (37). In this regard, the kidneys are unique in terms of the tissue concentrations of ANG II, which are much greater than can be explained by the concentrations delivered by the arterial blood flow (19). There is substantial evidence that the major fraction of ANG II present in renal tissues is generated locally from angiotensinogen (AGT) delivered to the kidney as well as from AGT locally produced by proximal tubule cells (18). Renin secreted by the juxtaglomerular apparatus cells i...